Immunic, Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to Immunic, Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update
(NASDAQ: IMUX) Delayed: 12.56 -0.18 (1.41%)
Previous Close $12.74    52 Week High
Open $12.72    52 Week Low
Day High $12.99    P/E N/A 
Day Low $12.40    EPS
Volume 84,707